Enter your login e-mail to the account
Search
- Cardiovascular toxicity of antineoplastic treatment
MUDr. Soňa Huľová, PhD.
(1/2026, Interdisciplinary consilium ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Current prospects in life-style and pharmacological control of adipose tissue morphological and functional characteristics in obese patients
Mgr. Zuzana Janáková, MUDr. RNDr. Lukáš Varga, PhD., Doc. MUDr. Barbara Ukropcová, PhD., Mgr. Jozef Ukropec, DrSc.
(4/2017, Topic of the year ) - THE ENDOCRINE FUNCTION OF ADIPOSE TISSUE
MUDr. Barbara Ukropcová, Mgr. Jozef Ukropec, PhD., prof. MUDr. Iwar Klimeš, DrSc., prof. MUDr. Ivan Tkáč, PhD.
(3/2008, Topic )
- Ketamine in clinical psychiatry and addictology – a narrative review
MUDr. Ondřej Vašíček, MUDr. Tomáš Páleníček, Ph.D.
(3/2026, Review articles ) - New perspectives in the treatment of bipolar affective disorder
MUDr. Iveta Fiziková, MUDr. Milena Drímalová, CSc.
(1/2013, Review articles )
- News in the treatment of diabetic neuropathy
MUDr. Dana Halbichová
(6/2011, Review articles ) - MuSK antibody positive myasthenia gravis – our experience
doc. MUDr. Peter Špalek, PhD., MUDr. Ivan Martinka, PhD., MUDr. Štefan Kečkeš
(2/2021, Main topic ) - Idiopathic inflammatory myopathies – new developments in treatment
MUDr. Heřman Mann, Ph.D.
(5/2025, Main topic ) - Diabetic Neuropathy – Neurologist Perspective
MUDr. Tomáš Nedělka, doc. MUDr. Martin Bojar, CSc., MUDr. Radim Mazanec, Ph.D.
(6/2009, Review articles ) - Precision neuro-oncology: reality and perspectives
Ing. et Ing. Jiří Polívka, Ph.D., MSc. Rashmi Negi, MUDr. Richard Koleják, MUDr. Jiří Polívka, CSc., MUDr. Pavel Potužník, Ph.D.
(5/2023, Main topic )
- One morning, when Gregor Samsa woke from troubled dreams
MUDr. Veronika Vestenická, PhD.
(2/2017 ) - Achondroplasia – orphan disease, orphan treatment
MUDr. Ľubica Tichá, PhD., MPH
(5/2022, Encyclopedia of rare diseases )
- Current options and trends in treating erectile dysfunction
MUDr. Otakar Štanc
(3/2018, SEXUAL AND REPRODUCTIVE MEDICINE FOR PRACTICE ) - Drug interactions in the treatment of kidney cancer
Mgr. Lucie Kovářová, PharmDr. Milada Halačová, Ph.D.
(3/2026, Drug interaction ) - Treatment of metastatic clear-cell renal cell carcinoma – cabozantinib – experience and inclusion in treatment algorithm
MUDr. Jana Katolická, Ph.D., MUDr. Sabina Svobodová, doc. MUDr. Jiří Vaníček, Ph.D., Mgr. Pavlína Prosecká, MUDr. Petr Filipenský, Ph.D.
(4/2018, Review articles ) - Management of the metastatic renal cancer
doc. MUDr. Jaroslav Pacovský, Ph.D.
(1/2023, Review articles ) - Imunoterapie u nádorů ledvin
MUDr. Andrea Ondrušková, doc. MUDr. Hana Študentová, Ph.D.
(3/2023, Review articles ) - Treatment of urothelial carcinoma bladder cancer
MUDr. Jana Katolická, Ph.D., MUDr. Lucia Tomková
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Erdafitinib in treatment of advanced urothelial carcinoma
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.L.
(3/2026, Drugs & drug classes ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - New Therapeutic Opportunities in Chronic Lymphocytic Leukemia
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Matej Hrnčár
(6/2014, Oncohematology Review ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - The genetic profile is determinating the choice of treatment of de-novo patients with chronic lymphocytic leukemia
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD., MUDr. Jozef Lukáš, PhD.
(2/2024, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Systemic treatment of neuroendocrine tumours
MUDr. Katarína Štefániková
(5/2021, Main topic ) - Innovative treatment of chronic lymphocytic leukemia using chemo-free strategies, ringing the bell for chemotherapy?
MUDr. Firas Farkaš, PhD.
(5/2021, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Systemic treatment of local advanced non resekability or metastatic urothelial carcinoma
MUDr. Jana Obertová, PhD.
(2/2021, Review articles ) - Hereditary form of malignant melanoma associated with mutations in CDKN2A gene
doc. MUDr. Juraj Kaušitz, CSc., RNDr. Zdena Bartošová, CSc., RNDr. Miriam Milly, PhD., RNDr. Michal Konečný, PhD., RNDr. Katarína Závodná, PhD., RNDr. Eva Weismanová, PhD.
(2/2010, Review articles ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - Acute myeloblastic leukemia in Slovakia and the presence of the FLT3 mutation
MUDr. Eva Mikušková, PhD.
(2/2021, Original articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Latent tuberculosis – risk factors of tuberculosis
MUDr. Jana Malinová, MUDr. Marta Hájková, CSc., MUDr. Antónia Hatalová, PhD., doc. MUDr. Emőke Šteňová, PhD.
(2/2019, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Treatment options in EGFR-mutated non-small cell lung cancer
MUDr. Marcela Vojčiaková, MUDr. Branislav Bystrický, PhD., MPH, MUDr. Filip Kohútek, PhD., MUDr. Júlia Vidulin, MUDr. Zuzana Miklátková
(1/2026, Review articles ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Bratislavské onkologické dni, LVII. ročník – odborný program a abstrakty
Kolektív autorov
(S3/2020, Abstracts ) - Recommendations for the management of patients with chronic myelocytic leukemia in the Slovak Republic
Kolektív autorov
(S1/2021, Supplement ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Gastrointestinal stromal tumors (GISTs)
MUDr. Iveta Andrezálová Vochyanová
(3/2011, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Systemic therapy of gastroenteropancreatic neuroendocrine tumors
MUDR. Tomáš Šálek
(5/2017, Main topic ) - Targeted diagnosis of endometrial cancer
doc. MUDr. Karol Kajo, PhD., MUDr. Peter Šuran, MUDr. Katarína Macháleková, PhD., Mgr. Lenka Kalinková, PhD., RNDr. Ivana Fridrichová, CSc.
(5/2020, Main topic ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - New recommendations for adjuvant and first-line treatment of metastatic clear cell renal carcinoma
MUDr. Milan Krošlák
(4/2022, Main topic ) - Circulating tumor DNA in non-small cell lung cancer patients with epidermal growth factor receptor mutations
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal, prof. MUDr. Eva Rozborilová, CSc.
(5/2020, Review articles ) - Solving clinical problems in the treatment of myelofibrosis - how to prevent ruxolitinib failure
MUDr. Antónia Hatalová, PhD.
(4/2022, Review articles ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Polycythemia vera – treatment options and today‘s practice
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(4/2019, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Ruxolitinib for GvHD treatment
MUDr. Barbora Žiaková, MUDr. Eva Bojtárová, PhD., MUDr. Michaela Martišová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(4/2022, Drugs & drug classes ) - Can we expect „ A new era“ in melanoma?
MUDr. Zuzana Hlavatá
(5/2011, Review articles ) - Relevance of the PI3K signaling pathway in advanced breast cancer and the possibilities of targeted treatment
MUDr. Bela Mriňáková, PhD., MPH
(5/2020, Review articles ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Publikujeme v zahraničí
Kolektív autorov
(4/2022, Information & comments ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Aktuálne možnosti diagnostiky a liečby pacientov s ALK+ NSCLC
Kolektív autorov
(S4/2020, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Systemic therapy of metastatic melanoma
MUDr. Tomáš Šálek
(6/2021, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - Diagnosis and treatment of malignant mesothelioma
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2019, Main topic ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Exon 20 insertions and other uncommon EGFR mutations in non-small cell lung cancer
MUDr. Gabriela Chowaniecová, PhD., prof. MUDr. Dalibor Ondruš, DrSc.
(4/2023, Review articles ) - Publikujeme v zahraničí
Kolektív autorov
(6/2021, Information & comments ) - Novinky z ASCO 2023, 15. ročník
MUDr. Mária Rečková, PhD.
(4/2023, Events ) - The present approach to treatment of renall cell carcinoma
MUDr. Zuzana Syčová-Milá
(5/2010, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - Gastrointesintal stromal tumors – new possibilities in the strategy of treatment
MUDr. Matej Hrnčár, MUDr. Eva Pritzová
(1/2019, Main topic ) - Antibody-drug conjugates and bispecific T-cell engagers in the treatment of advanced lung cancer
MUDr. Filip Kohútek, PhD., MUDr. Júlia Vidulin, MUDr. Branislav Bystrický, PhD., MPH
(4/2026, Main topic ) - Advances in molecular monitoring and the importance of screening BCR/ABL1 mutation for Ph-positive chronic myelocytic leukemia
MUDr. Adriana Kafková, PhD., prof. MUDr. Elena Tóthová, CSc.
(1/2019, Review articles ) - State of the art and treatment perspectives of penile cancer
Doc. MUDr. Katarína Rejleková, PhD.
(3/2024, Main topic ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Bratislavské onkologické dni, LX. ročník – odborný program a abstrakty
Kolektív autorov
(S1/2023, Abstracts ) - Effectivity of reduced dose of afatinib in patient with metastatic del 19 adenocarcinoma
MUDr. Michal Urda, MUDr. Simona Laštíková, MUDr. Juraj Mazal
(3/2020, Case reports ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - New trends in the treatment of Ph+ acute lymphoblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., MUDr. Iveta Simančíková, MUDr. Ladislav Sopko, PhD., MUDr. Katarína Slezáková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2017, Original articles & case reports ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Common mechanisms in the biology of aging and carcinogenesis: selected strategies for their targeting
Prof. MUDr. Beata Mladosievičová, CSc., RNDr. Zuzana Országhová, PhD.
(6/2020, Main topic ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - FLT3mutácie u pacienta s AML: incidencia, možnosti diagnostiky a vplyv na manažment liečby
MUDr. Eva Mikušková, PhD., RNDr. Renata Lukačková, RNDr. Imrich Hikkel, PhD., Mgr. Michaela Zrubcová
(3/2018, Original articles & case reports ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Treatment of patients with growing teratoma syndrome in nonseminomatous germ cell tumors
MUDr. Katarína Rejleková, PhD.
(5/2022, Review articles ) - Treatment options for acute myeloid leukemia in 2024
MUDr. Balázs Gálffy, PhD., MUDr. Ladislav Sopko, PhD., MPH, MUDr. Jozef Lukáš, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2024, Review articles ) - Non-metastatic triple-negative breast cancer – biological properties and current management
Prof. MUDr. Erik Kúdela, PhD., MBA, MUDr. Eva Kúdelová, PhD.
(6/2024, Review articles ) - Pheochromocytoma and paraganglioma
MUDr. Mária Rečková
(2/2013, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Treatment of myelofibrosis in time ruxolitinib
MUDr. Antónia Hatalová, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2020, Review articles ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Advances in the treatment of T-cell lymphomas
MUDr. Lucia Petríková, PhD., MUDr. Andrej Vranovský, PhD., doc. MUDr. Ľuboš Drgoňa, CSc.
(6/2022, Main topic ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - CHRONIC MYELOID LEUKEMIA – NEW TRENDS IN THE TREATMENT
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(5/2008, Review articles ) - Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia
MUDr. Juraj Chudej, PhD., MBA, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ľudmila Lineková, MUDr. Monika Péčová, MUDr. Lenka Lisá, PhD.
(2/2023, Review articles ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - Current therapeutic options for advanced and metastatic biliary tract cancer
MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Natália Pazderová, MUDr. Benjamin Špánik, MUDr. Štefan Pörsök, PhD., MPH
(5/2025, Main topic ) - The treatment of metastatic malignant melanoma
MUDr. Melinda Kráčalíková
(4/2024, Main topic ) - Use of nivolumab in solid tumours
MUDr. Katarína Bahnová
(4/2024, Review articles ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes ) - Case report of a patient with acute myeloid leukemia on maintenance therapy with gilteritinib after allogeneic transplantation
MUDr. Renáta Pizurová, MUDr. Kristína Mária Beláková, doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Ladislav Sopko, PhD.
(5/2025, Case reports ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - Mantle cell lymphoma
MUDr. Radoslav Greksák, PhD.
(1/2024, Main topic ) - TREATMENT OF CHRONIC MYELOID LEUKEMIA IN KHAT BRATISLAVA DURING 2002 – 2007
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, MUDr. Eva Demečková
(6/2008, Original articles ) - Publikujeme v zahraničí
(1/2016, Information & comments ) - The role of osimertinib in the treatment of lung cancer
MUDr. Anna Kollárová
(1/2024, Drugs & drug classes ) - Treatment of chronic lymphocytic leukemia with second-generation Bruton›s tyrosine kinase inhibitors – retrospective analysis and clinical experience
MUDr. Firas Farkaš, PhD., MUDr. Zdenka Štefániková, prof. MUDr. Angelika Bátorová, PhD.
(6/2025, Original articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Treatment of patients with FLT3 positive acute myeloblastic leukemia
MUDr. Firas Farkaš, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2019, Review articles ) - Treatment of BRAF wt metastatic colorectal cancer
MUDr. Vanda Ušáková, PhD.
(4/2021, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - The treatment of clear cell renal carcinoma
MUDr. Jana Obertová, PhD.
(4/2021, Review articles ) - Systemic treatment of advanced hepatocellular carcinoma
MUDr. Štefan Pörsök, PhD., MUDr. Natália Pazderová, MUDr. Eva Zomborská, MUDr. Ján Slopovský, MUDr. Tomáš Šálek
(6/2019, Main topic ) - Prognostic and predictive biomarkers in renal cell carcinoma
MUDr. Zuzana Tomčová, MPH
(3/2025, Oncology by doctoral students ) - Pathogenesis of chronic lymphocytic leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(2/2014, Oncohematology Review ) - Mantle cell lymphoma
MUDr. Miriam Ladická
(4/2017, Spectrum ) - Cardiovascular complications caused by treatment of hematologic malignancies
Prof. MUDr. Beata Mladosievičová, PhD.
(4/2017, Review articles ) - A new approach to the treatment of CML with a value-added drug
MUDr. Ľubica Váleková, PhD., doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Emília Flochová, PhD.
(1/2025, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - Ibrutinib in treatment of Waldenström´s makroglobulinemia – case report
MUDr. Aneta Matysová
(4/2017, Original articles & case reports ) - Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment
MUDr. Dagmar Sudeková
(1/2018, Main topic ) - Cancer and genetics: friends or foes?
RNDr. Zuzana Šestáková, PhD., MUDr. Filip Chovanec, Mgr. Miroslav Chovanec, PhD.
(6/2018, Main topic ) - The effect of ruxolitinib on quality of life – a case report
MUDr. Daniela Kubincová
(S2/2020, Case reports ) - Publikujeme v zahraničí
Kolektív autorov
(1/2025, Information & comments ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Acute promyelocytic leukemia - pathogenesis, diagnostics, prognosis (part I.)
MUDr. Iveta Oravcová
(3/2009, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Malignant melanoma – clinical image, diagnosis and treatment
MUDr. Andrea Kozárová, PhD., doc. MUDr. Eva Minariková, PhD.
(3/2020, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Genetic background of skin tumors
MUDr. Zuzana Murárová, PhD.
(3/2024, Topic of the year ) - Upadacitinib in the treatment of atopic dermatitis
MUDr. Karolína Vorčáková, PhD.
(2/2023, Drugs and drug groups )
- GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly )
- Targeted biologic therapies and related side effects in most common cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2009, Review articles )
- Interactions of the antineoplastic drugs with other drugs
PharmDr. Andrej Džongov
(4/2024, Current pharmacotherapy ) - Current trends in treatment of atopic dermatitis – a minimum for pharmacists
MUDr. Petra Brodská, Ph.D.
(3/2023, Current pharmacotherapy ) - Pharmacokinetic drug-drug interactions of direct oral anticoagulants
PharmDr. Josef Suchopár, MUDr. Michal Prokeš, Mgr. Štěpán Suchopár
(1-2/2026, Current pharmacotherapy )
- XXV. Slovensko-Česká konferencia o hemostáze a trombóze s medzinárodnou účasťou
Kolektív autorov
(S1/2018, Abstracts ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles )
- Gastrointestinal stromal tumor (GIST) of duodenum manifested as gastrointestinal bleeding – case report
MUDr. Ivan Kováč, PhD., MUDr. Marián Kudláč, doc. MUDr. Jozef Belák, PhD., MUDr. Peter Švajdler, MUDr. Martin Novotný, MPH
(1/2017, Case report ) - Stomach gists in our repertoire of patients
MUDr. Vladimír Dudáš, doc. MUDr. Augustín Prochotský, CSc., MUDr. Martin Nemček, MUDr. Peter Levčík
(3-4/2018, Case report ) - Multivisceral resection as a treatment option for a large gastrointestinal stromal tumor - a case report
MUDr. Monika Miklóšová, doc. MUDr. Jozef Belák, PhD., MUDr. Marián Kudláč, MUDr. Ivan Kováč, PhD.
(1-2/2020, Case report )
- Current possibilities of genetic testing of endocrine neoplasias
RNDr. Aster Alemayehu, PhD., Mgr. Michal Svoboda, PhD.
(1/2025, Main topic ) - Analýza slovenského genómu: Predbežné údaje pre budúci výskum
Mgr. Patrik Krumpolec, PhD., Mgr. Klaudia Babišová, RNDr. Michaela Hýblová, PhD., MSc. Andrej Gnip, Mgr. Dominik Hadžega, PhD., Oliver Petrovič, RNDr. Gabriel Minárik, PhD.
(2/2024, Main topic )